This event is fully booked!  To be added to the wait list, please call the BioMelbourne Network office on 03 9667 8181

You are invited to this BioBreakfast to hear CSIRO and MTPConnect (Medical Technology and Pharmaceuticals Industry Innovation Growth Centre) leaders outline the key findings of the Medtech and Pharma Roadmap; the alignment to MTPConnect’s Sector Competitiveness Plan and the future directions of CSIRO’s Health Portfolio.

A key strategic action of CSIRO’s Strategy 2020 was to deliver and act upon market and technology roadmaps to support national challenges and industry innovation. CSIRO has worked with MTPConnect, industry and academia to develop a Medtech and Pharma Roadmap which will be released in coming weeks. The Roadmap complements the MTP Sector Competitiveness Plan which was released in December 2016. In addition, CSIRO has recently appointed a new Director of Health and Biosecurity and has developed an Organisation Health Strategy.

MTPConnect is an independent, not-for-profit organisation aiming to accelerate the rate of growth of the medical technologies, biotechnologies and pharmaceuticals (MTP) sector to achieve greater commercialisation and establish Australia as an Asia-Pacific hub for MTP companies. MTPConnect was established in November 2015 as part of the Federal Government’s $250 million Industry Growth Centres Initiative.

After broad sector consultation and review, and collaboration and alignment with the CSIRO Roadmap, MTPConnect published its 10-year Sector Competitiveness Plan in December 2016, outlining a strategy to foster collaboration, seize commercialisation opportunities, strengthen the economy, and secure the health of Australians into the future.

Dr Alfredo Martinez-Coll, the General Manager of Stakeholder Engagement at MTPConnect, will provide an overview of the Sector Competitiveness Plan and Sector Growth Priorities, and how MTPConnect is implementing it to boost the sector.

Date: Tuesday 4th April 2017
Time: Registration from 7:20am for a 7.30am breakfast networking followed by presentations and discussion from 8.00am – 9:00am
Venue: CSIRO Parkville, 343 Royal Parade, Parkville Vic 3052, Australia

Cost:
Members: $65
Non-Members: $130
(Prices include GST)

To check if your organisation is a member, click here

Cancellation Policy:
Full refund given up to 7 days prior to the event
No refunds within 7 days of the event

Speakers:

Dr Keith McLean, Director, CSIRO Manufacturing

Dr Keith McLean joined CSIRO in 1989 and is currently the Director of Manufacturing where he leads 400 scientists and engineers developing solutions for high-tech Australian manufacturing. In particular, CSIRO Manufacturing is directed to research in Biomedical Manufacturing; Chemical and Fibre Industries; Metals Manufacturing and Innovative Manufacturing.
He is a Board Member of the CRC Polymers; Biomedical Research Victoria and veski and is a Council Member of the Australian Advanced Manufacturing Council (2015 – present) and the Advisory Council of Chemistry Australia.

Dr Alfredo Martinez-Coll – General Manager, Stakeholder Engagement, MTPConnect

Dr Martinez-Coll is a Graduate of the Australian Institute of Company Directors, a Registered Technology Transfer Professional and a member of the NSW AusMedTech (Medical Devices) Committee of AusBiotech. With a B.S. in Biomedical Engineering from Louisiana Tech University (USA), a PhD and post-doctoral training in biomedical sciences from University of Technology, Sydney, Alfredo brings more than 16 years research experience in the areas of artificial organs, cardiovascular and cerebrovascular physiology, membrane transport, and oxygen transport to tissue.

Alfredo has worked as a business development manager in Technology Transfer/commercialisation for the past 13 years at public hospitals and in academia, and most recently held the position of Senior Business Development Manager at UNSW Innovations.

Dr Rob Grenfell, Director, CSIRO Health & Biosecurity, CSIRO

Dr Rob Grenfell joined CSIRO in June 2016 as the Health Director of the Health and Biosecurity Business Unit.

Rob was previously the National Medical Director of Bupa Australia and New Zealand. He has also held roles as the National Director of Cardiovascular Health at the Heart Foundation and as the Strategic Health Advisor to Parks Victoria and previously a Senior Medical Advisor at the Department of Health Victoria.

Hosted by: